366 related articles for article (PubMed ID: 26573548)
1. The Pathogenesis and Therapeutic Implications of Tubulointerstitial Inflammation in Human Lupus Nephritis.
Clark MR; Trotter K; Chang A
Semin Nephrol; 2015 Sep; 35(5):455-64. PubMed ID: 26573548
[TBL] [Abstract][Full Text] [Related]
2. Brief Report: Tubulointerstitial Damage in Lupus Nephritis: A Comparison of the Factors Associated With Tubulointerstitial Inflammation and Renal Scarring.
Londoño Jimenez A; Mowrey WB; Putterman C; Buyon J; Goilav B; Broder A
Arthritis Rheumatol; 2018 Nov; 70(11):1801-1806. PubMed ID: 29851285
[TBL] [Abstract][Full Text] [Related]
3. Bcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation.
Ko K; Wang J; Perper S; Jiang Y; Yanez D; Kaverina N; Ai J; Liarski VM; Chang A; Peng Y; Lan L; Westmoreland S; Olson L; Giger ML; Chun Wang L; Clark MR
Arthritis Rheumatol; 2016 Nov; 68(11):2740-2751. PubMed ID: 27159593
[TBL] [Abstract][Full Text] [Related]
4. Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis.
Kinloch AJ; Chang A; Ko K; Henry Dunand CJ; Henderson S; Maienschein-Cline M; Kaverina N; Rovin BH; Salgado Ferrer M; Wolfgeher D; Liarski V; Haddon DJ; Utz PJ; Wilson PC; Clark MR
Arthritis Rheumatol; 2014 Dec; 66(12):3359-70. PubMed ID: 25306868
[TBL] [Abstract][Full Text] [Related]
5. Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity.
Nasr SH; D'Agati VD; Park HR; Sterman PL; Goyzueta JD; Dressler RM; Hazlett SM; Pursell RN; Caputo C; Markowitz GS
Clin J Am Soc Nephrol; 2008 May; 3(3):682-90. PubMed ID: 18287252
[TBL] [Abstract][Full Text] [Related]
6. Non-albumin proteinuria as a parameter of tubulointerstitial inflammation in lupus nephritis.
Kwon OC; Park Y; Lee JS; Oh JS; Kim YG; Lee CK; Yoo B; Hong S
Clin Rheumatol; 2019 Jan; 38(1):235-241. PubMed ID: 30094751
[TBL] [Abstract][Full Text] [Related]
7. Update on Lupus Nephritis: Core Curriculum 2020.
Parikh SV; Almaani S; Brodsky S; Rovin BH
Am J Kidney Dis; 2020 Aug; 76(2):265-281. PubMed ID: 32220510
[TBL] [Abstract][Full Text] [Related]
8. Lupus nephritis: from pathogenesis to targets for biologic treatment.
Liu Y; Anders HJ
Nephron Clin Pract; 2014; 128(3-4):224-31. PubMed ID: 25401461
[TBL] [Abstract][Full Text] [Related]
9. Cellular aspects of the pathogenesis of lupus nephritis.
Chang A; Clark MR; Ko K
Curr Opin Rheumatol; 2021 Mar; 33(2):197-204. PubMed ID: 33394604
[TBL] [Abstract][Full Text] [Related]
10. Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring.
Hsieh C; Chang A; Brandt D; Guttikonda R; Utset TO; Clark MR
Arthritis Care Res (Hoboken); 2011 Jun; 63(6):865-74. PubMed ID: 21309006
[TBL] [Abstract][Full Text] [Related]
11. Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane.
Summers SA; Odobasic D; Khouri MB; Steinmetz OM; Yang Y; Holdsworth SR; Kitching AR
Clin Exp Immunol; 2014 Jun; 176(3):341-50. PubMed ID: 24528105
[TBL] [Abstract][Full Text] [Related]
12. Predominant tubulointerstitial nephritis in a patient with systemic lupus erythematosus: phenotype of infiltrating cells.
Omokawa A; Wakui H; Okuyama S; Togashi M; Ohtani H; Komatsuda A; Ichinohasama R; Sawada K
Clin Nephrol; 2008 Jun; 69(6):436-44. PubMed ID: 18538120
[TBL] [Abstract][Full Text] [Related]
13. In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis.
Chang A; Henderson SG; Brandt D; Liu N; Guttikonda R; Hsieh C; Kaverina N; Utset TO; Meehan SM; Quigg RJ; Meffre E; Clark MR
J Immunol; 2011 Feb; 186(3):1849-60. PubMed ID: 21187439
[TBL] [Abstract][Full Text] [Related]
14. Tubulointerstitial disease in lupus nephritis: relationship to immune deposits, interstitial inflammation, glomerular changes, renal function, and prognosis.
Park MH; D'Agati V; Appel GB; Pirani CL
Nephron; 1986; 44(4):309-19. PubMed ID: 3540691
[TBL] [Abstract][Full Text] [Related]
15. Interstitial inflammatory and chronic tubulointerstitial lesions in lupus nephritis: comparison with those in IgA nephropathy.
Yamamoto T; Nagase M; Hishida A; Honda N
Lupus; 1993 Aug; 2(4):261-8. PubMed ID: 8268975
[TBL] [Abstract][Full Text] [Related]
16. Tubulointerstitial nephritis in systemic lupus erythematosus: innocent bystander or ominous presage.
Dhingra S; Qureshi R; Abdellatif A; Gaber LW; Truong LD
Histol Histopathol; 2014 May; 29(5):553-65. PubMed ID: 24288339
[TBL] [Abstract][Full Text] [Related]
17. Chronicity index, especially glomerular sclerosis, is the most powerful predictor of renal response following immunosuppressive treatment in patients with lupus nephritis.
Park DJ; Choi SE; Xu H; Kang JH; Lee KE; Lee JS; Choi YD; Lee SS
Int J Rheum Dis; 2018 Feb; 21(2):458-467. PubMed ID: 29314776
[TBL] [Abstract][Full Text] [Related]
18. A pathophysiology-based approach to the diagnosis and treatment of lupus nephritis.
Anders HJ; Rovin B
Kidney Int; 2016 Sep; 90(3):493-501. PubMed ID: 27378475
[TBL] [Abstract][Full Text] [Related]
19. A novel pathogenetic concept-antiviral immunity in lupus nephritis.
Migliorini A; Anders HJ
Nat Rev Nephrol; 2012 Jan; 8(3):183-9. PubMed ID: 22249778
[TBL] [Abstract][Full Text] [Related]
20. Lupus nephritis: update on mechanisms of systemic autoimmunity and kidney immunopathology.
Lorenz G; Desai J; Anders HJ
Curr Opin Nephrol Hypertens; 2014 May; 23(3):211-7. PubMed ID: 24662982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
